Insights from the axillary vein puncture guided by ultrasound versus cephalic vein dissection trial.
Ana Paula TagliariAdriano Nunes KochiRodrigo Petersen SaadiBernardo MastellaEduardo Keller SaadiCarísi Anne PolanczykPublished in: Future cardiology (2021)
Axillary vein puncture guided by ultrasound (US-Ax) versus cephalic vein dissection in pacemaker and defibrillator implant: a multicenter randomized clinical trial is a recently published study in which 88 patients were randomized in a 1:1 fashion to one of the two methods. Even being performed by operators with not previous ultrasound-guided axillary vein puncture experience, this group presented a higher success rate, lower procedural time and comparable complication incidence.
Keyphrases
- ejection fraction
- ultrasound guided
- fine needle aspiration
- double blind
- lymph node
- phase iii
- magnetic resonance imaging
- clinical trial
- neoadjuvant chemotherapy
- sentinel lymph node
- open label
- phase ii
- randomized controlled trial
- study protocol
- risk factors
- squamous cell carcinoma
- heart failure
- left ventricular
- chronic kidney disease
- cross sectional
- newly diagnosed
- computed tomography
- end stage renal disease
- early stage
- vena cava
- prognostic factors
- patient reported outcomes
- cardiac resynchronization therapy
- pulmonary embolism
- rectal cancer
- peritoneal dialysis